Maria Josic, MS

Principal Scientist
Pfizer
San Diego, California

Disclosure information not submitted.

Presentation(s):

• (PA-039) Differential Impact of BCMA (TNFRSF17) Extracellular Domain Mutations on in vitro Potency of Elranatamab versus Teclistamab

  Wednesday, September 17, 2025
  12:08 - 12:14 East Coast USA Time